避孕药具市场规模、份额及成长分析（按产品、通路及地区划分）－2026-2033年产业预测

预计到 2024 年，避孕药具市场规模将达到 325.5 亿美元，到 2025 年将成长至 349.6 亿美元，到 2033 年将成长至 618.9 亿美元，预测期（2026-2033 年）的复合年增长率为 7.4%。

受多种因素驱动，全球避孕市场正经历显着扩张。人们对计划生育意识的提高以及性行为感染（STI）发生率的上升是推动这一增长的核心动力。此外，技术进步（包括长效可逆避孕方法（LARCs））和选择的增加也促进了对有效避孕措施的需求。政府为促进计划生育和生殖健康所采取的措施进一步巩固了这一有利局面。然而，该市场也面临许多挑战，例如社会偏见、文化障碍以及部分地区避孕服务取得受限等。儘管存在这些障碍，但人们对女性健康的日益关注以及对避孕作为一种赋权手段的接受度不断提高，预计将显着推动该市场的未来发展。

避孕药市场成长要素

推动避孕药具市场成长的主要因素是人们对计划生育和生殖健康的认识和接受度不断提高。随着人们对避孕在控制人口成长和促进女性健康方面的益处了解的加深，避孕方法的需求激增。政府推行的计划生育倡议和项目进一步强化了这一趋势。此外，众多组织在提高大众对不同避孕方式的认识方面发挥着至关重要的作用，从而促进了社会对相关知识的了解。这些共同努力正在推动市场需求的成长，并扩大人们获得生殖健康解决方案的途径。

避孕药市场限制

全球避孕器市场面临许多限制因素，主要包括文化和宗教障碍，这些障碍阻碍了不同地区对避孕方法的接受和使用。在某些社区，传统信仰和宗教教义抑製或限制了避孕器的使用，导致其普及率较低。另一个挑战是避孕选择管道匮乏，尤其是在农村和医疗服务不足的地区。供应有限、高成本以及分销网络不完善等因素会阻碍避孕药具的有效使用，尤其是在开发中国家。消除这些文化和后勤障碍对于扩大可靠避孕方法的覆盖范围和促进市场成长至关重要。

避孕器市场趋势

全球避孕器市场的一个显着趋势是，人们对长效可逆避孕方法（LARCs）的兴趣日益浓厚，例如子宫内避孕器（IUD）和皮下植入。由于其高效性和低维护成本，这些方法越来越受到寻求可靠便捷避孕方案的女性的青睐。科技进步也推动了LARCs的普及，带来了更多创新且人性化的设计，进一步提升了其吸引力。这一成长趋势凸显了人们对有效且永续避孕方法的普遍需求，也反映了全球对计划生育和生殖健康观念的转变。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步
• 监管环境
• 案例研究
• 客户和购买标准分析
• 贸易分析
• 原料分析

全球避孕药具市场规模（依产品划分）及复合年增长率（2026-2033 年）

• 避孕药
  • 避孕药
  • 修补
  • 注射
• 避孕装置
  • 保险套
  • 男用保险套
  • 女性用保险套
  • 皮下植入式避孕器
  • 子宫内避孕器（IUD）
  • 含铜子宫内避孕器（IUD）
  • 含激素子宫内避孕器（IUD）
  • 阴道环
  • 阴道内避孕环

全球避孕药具市场规模（依通路划分）及复合年增长率（2026-2033 年）

• 医疗机构
• 药局
• 其他的

全球避孕药具市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Bayer AG
• Pfizer Inc.
• Merck & Co., Inc.
• Teva Pharmaceutical Industries Ltd.
• Organon & Co.
• Agile Therapeutics
• Mayer Laboratories, Inc.
• CooperSurgical, Inc.
• Afaxys, Inc.
• Mylan NV（Viatris）
• DKT International
• Medisafe Distribution Inc.
• Veru Inc.
• Cipla Ltd.
• Lupin Pharmaceuticals
• Mithra Pharmaceuticals
• Pregna International Limited
• Fuji Latex Co., Ltd.
• Karex Berhad
• Cupid Limited

结论与建议

Contraceptives Market size was valued at USD 32.55 Billion in 2024 and is poised to grow from USD 34.96 Billion in 2025 to USD 61.89 Billion by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The global contraceptives market is experiencing notable expansion due to various driving factors. Growing awareness around family planning and a heightened incidence of sexually transmitted infections (STIs) are central to this growth. Additionally, the demand for effective contraceptive methods is on the rise, supported by advancements in technology, including long-acting reversible contraceptives (LARCs) and an expanding array of options. Government initiatives advocating for family planning and reproductive health further enhance this positive landscape. However, the market faces challenges, including social stigma, cultural barriers, and restricted access in some regions. Despite these obstacles, the increasing focus on women's health and the broadening acceptance of contraception as a means of empowerment are poised to significantly bolster the market's future development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contraceptives market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contraceptives Market Segments Analysis

Global Contraceptives Market is segmented by product, distribution channel and region. Based on product, the market is segmented into contraceptive drugs and contraceptive devices. Based on distribution channel, the market is segmented into healthcare facilities, pharmacies and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contraceptives Market

A major catalyst for growth in the contraceptives market is the rising awareness and acceptance surrounding family planning and reproductive health. As people gain more knowledge about the benefits of contraception for managing population growth and enhancing women's health, the demand for contraceptive methods has surged. This trend is further bolstered by government initiatives and programs designed to advocate for family planning. Additionally, various organizations play a significant role in raising awareness about different contraceptive options, thereby fostering a more informed public. This collective effort is driving an increase in market demand and expanding access to reproductive health solutions.

Restraints in the Contraceptives Market

The global contraceptives market faces significant restraints primarily due to cultural and religious barriers that hinder the acceptance and utilization of contraceptive methods in various regions. In certain communities, traditional beliefs and religious doctrines discourage or limit the use of contraceptives, resulting in lower adoption rates among the population. Additionally, inadequate access to contraceptive options, particularly in rural and underserved areas, poses a challenge. Factors such as limited availability, high costs, and insufficient distribution networks can obstruct the effective use of contraceptives, particularly in developing nations. Addressing these cultural and logistical hurdles is essential for promoting greater accessibility to reliable contraception and fostering the market's growth.

Market Trends of the Contraceptives Market

A prominent trend in the global contraceptives market is the surging interest in long-acting reversible contraceptives (LARCs), such as intrauterine devices (IUDs) and contraceptive implants. These options are increasingly favored by women due to their high efficacy and low maintenance requirements, thereby addressing the need for reliable and convenient birth control solutions. The shift towards LARCs is also driven by technology advancements that have introduced more innovative and user-friendly designs, enhancing their appeal. This growing trend underscores a broader movement towards effective, sustainable contraceptive methods, reflecting changing attitudes towards family planning and reproductive health globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis
• Trade Analysis
• Raw Material Analysis

Global Contraceptives Market Size by Product & CAGR (2026-2033)

• Market Overview
• Contraceptive Drugs
  • Contraceptive Pills
  • Patch
  • Injectables
• Contraceptive Devices
  • Condom
  • Male Condom
  • Female Condom
  • Subdermal Implants
  • Intrauterine Devices (IUDS)
  • Copper IUDS
  • Hormonal IUDS
  • Vaginal Ring
  • Diaphragm

Global Contraceptives Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Healthcare Facilities
• Pharmacies
• Others

Global Contraceptives Market Size & CAGR (2026-2033)

• North America (Product, Distribution Channel)
  • USA
  • Canada
• Europe (Product, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mithra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Latex Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karex Berhad
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cupid Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations